心脏移植术被确认为终末期心脏病人的重要治疗方法后 ,一个决定因素是适当的心脏保存。目前 ,心脏冷缺血保存被限制在 4～ 6ｈ ,其有效保存在很大程度上要依赖于保存液和保存温度[1 ] 。现就心脏保存液的研究进展综述如下 :1　细胞内液型和细胞外液型保存液心脏保存效果比较细 After heart transplantation is recognized as an important treatment for end-stage heart disease, a determinant is proper heart preservation. At present, preservation of cold ischemia in the heart is limited to 4 to 6 hours, and its effective preservation depends to a large extent on the preservation solution and the preservation temperature [1]. Cardiac preservation solution now on the progress of research are summarized as follows: 1 intracellular fluid and extracellular fluid preservation fluid heart preservation effect is relatively small